{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:33:36Z","timestamp":1793144016172,"version":"4.5.0"},"reference-count":154,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.semdp.2026.151028","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:57:26Z","timestamp":1780718246000},"page":"151028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["When three negatives equal a positive: Molecular updates of triple-negative breast carcinomas with favorable prognoses"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1202-9257","authenticated-orcid":false,"given":"Victoria M.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2596-2604","authenticated-orcid":false,"given":"S. Emily","family":"Bachert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.semdp.2026.151028_bib0001","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP guideline update","volume":"38","author":"Allison","year":"2020","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"11","key":"10.1016\/j.semdp.2026.151028_bib0002","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.5858\/arpa.2018-0902-SA","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology\/college of American pathologists clinical practice guideline focused update","volume":"142","author":"Wolff","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.semdp.2026.151028_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2020.576964","article-title":"Racial disparities in triple negative breast cancer: a review of the role of biologic and non-biologic factors","volume":"8","author":"Prakash","year":"2020","journal-title":"Front Public Health"},{"issue":"4","key":"10.1016\/j.semdp.2026.151028_bib0004","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrc3896","article-title":"Triple-negative breast cancer in African-American women: disparities versus biology","volume":"15","author":"Dietze","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/PPO.0000000000000500","article-title":"Epidemiology of triple-negative Breast cancer: a review","volume":"27","author":"Howard","year":"2021","journal-title":"Cancer J Sudbury Mass"},{"issue":"7","key":"10.1016\/j.semdp.2026.151028_bib0006","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1158\/0008-5472.CAN-12-1699","article-title":"Genetic susceptibility to triple-negative breast cancer","volume":"73","author":"Stevens","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.semdp.2026.151028_bib0007","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12943-018-0850-9","article-title":"Therapeutic landscape in mutational triple negative breast cancer","volume":"17","author":"Shi","year":"2018","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0008","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","article-title":"Triple negative breast cancer: pitfalls and progress","volume":"8","author":"Zagami","year":"2022","journal-title":"NPJ Breast Cancer"},{"issue":"6","key":"10.1016\/j.semdp.2026.151028_bib0009","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3892\/ijo.2020.5135","article-title":"Triple\u2011negative breast cancer therapy: current and future perspectives (Review)","volume":"57","author":"Won","year":"2020","journal-title":"Int J Oncol"},{"key":"10.1016\/j.semdp.2026.151028_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103643","article-title":"Low-risk triple-negative breast cancers: clinico-pathological and molecular features","volume":"172","author":"Fusco","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.semdp.2026.151028_bib0011","first-page":"48","article-title":"Histologic heterogeneity of triple negative breast cancer: a national cancer centre database analysis","volume":"98","author":"Mills","year":"2018","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"10.1016\/j.semdp.2026.151028_bib0012","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41523-020-00197-2","article-title":"Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies","volume":"6","author":"Marra","year":"2020","journal-title":"NPJ Breast Cancer"},{"issue":"6797","key":"10.1016\/j.semdp.2026.151028_bib0013","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.semdp.2026.151028_bib0014","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"S\u00f8rlie","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.semdp.2026.151028_bib0015","first-page":"264","article-title":"Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma","volume":"19","author":"Livasy","year":"2006","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"5","key":"10.1016\/j.semdp.2026.151028_bib0016","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/1078-0432.CCR-07-1658","article-title":"Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype","volume":"14","author":"Cheang","year":"2008","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0017","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10549-007-9632-6","article-title":"Epidemiology of basal-like breast cancer","volume":"109","author":"Millikan","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"Suppl 1","key":"10.1016\/j.semdp.2026.151028_bib0018","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1634\/theoncologist.2011-S1-61","article-title":"Molecular stratification of triple-negative breast cancers","volume":"16","author":"Perou","year":"2011","journal-title":"The Oncologist"},{"key":"10.1016\/j.semdp.2026.151028_bib0019","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","article-title":"Pathogenesis of Triple-Negative Breast Cancer","volume":"17","author":"Derakhshan","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.semdp.2026.151028_bib0020","doi-asserted-by":"crossref","DOI":"10.1038\/npjbcancer.2016.36","article-title":"Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants","volume":"2","author":"Pareja","year":"2016","journal-title":"NPJ Breast Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.semdp.2026.151028_bib0021","first-page":"38","article-title":"Problematic breast tumors reassessed in light of novel molecular data","volume":"34","author":"Pareja","year":"2021","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"15","key":"10.1016\/j.semdp.2026.151028_bib0022","doi-asserted-by":"crossref","first-page":"12890","DOI":"10.18632\/oncotarget.3849","article-title":"Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?","volume":"6","author":"Le Du","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.semdp.2026.151028_bib0023","doi-asserted-by":"crossref","first-page":"293","DOI":"10.20892\/j.issn.2095-3941.2019.0465","article-title":"Triple negative breast cancer: special histological types and emerging therapeutic methods","volume":"17","author":"Cao","year":"2020","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.semdp.2026.151028_bib0024","volume":"Vol. 2","year":"2019"},{"issue":"6","key":"10.1016\/j.semdp.2026.151028_bib0025","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.semdp.2024.10.003","article-title":"Salivary gland-like tumors of the breast: histopathologic and genetic features with clinical implications","volume":"41","author":"Schwartz","year":"2024","journal-title":"Semin Diagn Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0026","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.semdp.2009.12.007","article-title":"Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including \u201ctriple negative carcinomas\u201d of low malignant potential","volume":"27","author":"Foschini","year":"2010","journal-title":"Semin Diagn Pathol"},{"issue":"5","key":"10.1016\/j.semdp.2026.151028_bib0027","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.1966.03100050096033","article-title":"Breast carcinoma in children","volume":"195","author":"McDivitt","year":"1966","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0028","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1186\/s12887-023-04286-6","article-title":"A case report and literature review on a rare subtype of triple-negative breast cancer in children","volume":"23","author":"Shi","year":"2023","journal-title":"BMC Pediatr"},{"issue":"27","key":"10.1016\/j.semdp.2026.151028_bib0029","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000034192","article-title":"Secretory breast cancer in a boy: a case report with genetic analysis using next-generation sequencing and literature review","volume":"102","author":"Deng","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semdp.2026.151028_bib0030","article-title":"Successful targeted therapy of refractory pediatric ETV6-NTRK3 fusion-positive secretory breast carcinoma","volume":"2017","author":"Shukla","year":"2017","journal-title":"JCO Precis Oncol"},{"issue":"2","key":"10.1016\/j.semdp.2026.151028_bib0031","first-page":"291","article-title":"Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum","volume":"22","author":"La\u00e9","year":"2009","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"8","key":"10.1016\/j.semdp.2026.151028_bib0032","first-page":"1086","article-title":"Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas","volume":"30","author":"Krings","year":"2017","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"11","key":"10.1016\/j.semdp.2026.151028_bib0033","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1097\/PAS.0000000000000487","article-title":"Secretory breast carcinoma: a histopathologic and genomic spectrum characterized by a joint specific ETV6-NTRK3 gene fusion","volume":"39","author":"Del Castillo","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.semdp.2026.151028_bib0034","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1535-6108(02)00180-0","article-title":"Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma","volume":"2","author":"Tognon","year":"2002","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.semdp.2026.151028_bib0035","doi-asserted-by":"crossref","DOI":"10.1002\/prca.201700125","article-title":"Integrated multi-omic analyses support distinguishing secretory carcinoma of the breast from basal-like triple-negative breast cancer","volume":"12","author":"Jin","year":"2018","journal-title":"Proteomics Clin Appl"},{"issue":"7","key":"10.1016\/j.semdp.2026.151028_bib0036","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/jcp.2008.059675","article-title":"Genomic profile of a secretory breast cancer with an ETV6-NTRK3 duplication","volume":"62","author":"Lambros","year":"2009","journal-title":"J Clin Pathol"},{"issue":"5","key":"10.1016\/j.semdp.2026.151028_bib0037","first-page":"596","article-title":"NTRK fusions in solid tumours: what every pathologist needs to know","volume":"55","author":"Nguyen","year":"2023","journal-title":"Pathology (Phila)"},{"issue":"12","key":"10.1016\/j.semdp.2026.151028_bib0038","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0046-8177(03)00423-4","article-title":"Secretory carcinoma of the breast: a distinct variant of invasive ductal carcinoma assessed by comparative genomic hybridization and immunohistochemistry","volume":"34","author":"Diallo","year":"2003","journal-title":"Hum Pathol"},{"issue":"11","key":"10.1016\/j.semdp.2026.151028_bib0039","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1097\/PAS.0000000000000911","article-title":"Pan-Trk Immunohistochemistry Is an efficient and reliable screen for the detection of NTRK fusions","volume":"41","author":"Hechtman","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.semdp.2026.151028_bib0040","doi-asserted-by":"crossref","first-page":"E174","DOI":"10.1002\/dc.24945","article-title":"Cytological and molecular characterization of secretory breast carcinoma","volume":"50","author":"Carretero-Barrio","year":"2022","journal-title":"Diagn Cytopathol"},{"issue":"11","key":"10.1016\/j.semdp.2026.151028_bib0041","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/jcp-2023-208989","article-title":"Nuclear staining for pan-Trk by immunohistochemistry is highly specific for secretory carcinoma of breast: pan-Trk in various subtypes of breast carcinoma","volume":"77","author":"Ye","year":"2024","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0042","first-page":"38","article-title":"NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls","volume":"33","author":"Solomon","year":"2020","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"12","key":"10.1016\/j.semdp.2026.151028_bib0043","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1097\/PAS.0000000000001366","article-title":"Pan-TRK Immunohistochemistry: a useful diagnostic adjunct for secretory carcinoma of the breast","volume":"43","author":"Harrison","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.semdp.2026.151028_bib0044","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/pin.12766","article-title":"Non-secretory breast carcinomas lack NTRK rearrangements and TRK protein expression","volume":"69","author":"Remou\u00e9","year":"2019","journal-title":"Pathol Int"},{"issue":"2","key":"10.1016\/j.semdp.2026.151028_bib0045","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5306\/wjco.v13.i2.135","article-title":"Neurotrophic receptor tyrosine kinase family members in secretory and non-secretory breast carcinomas","volume":"13","author":"Stravodimou","year":"2022","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.semdp.2026.151028_bib0046","series-title":"Diagnostic Pathology: Breast","author":"Lester","year":"2025"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0047","doi-asserted-by":"crossref","first-page":"139","DOI":"10.20892\/j.issn.2095-3941.2018.0035","article-title":"Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma","volume":"16","author":"Li","year":"2019","journal-title":"Cancer Biol Med"},{"issue":"8","key":"10.1016\/j.semdp.2026.151028_bib0048","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children","volume":"378","author":"Drilon","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.semdp.2026.151028_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.105110","article-title":"Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancer","volume":"10","author":"Hong","year":"2025","journal-title":"ESMO Open"},{"key":"10.1016\/j.semdp.2026.151028_bib0050","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231152844","article-title":"TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis","volume":"15","author":"Medford","year":"2023","journal-title":"Ther Adv Med Oncol"},{"issue":"4","key":"10.1016\/j.semdp.2026.151028_bib0051","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2613","article-title":"Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study","volume":"12","author":"Ghabach","year":"2010","journal-title":"Breast Cancer Res BCR"},{"issue":"8","key":"10.1016\/j.semdp.2026.151028_bib0052","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1699-0463.1999.tb01470.x","article-title":"Basaloid type adenoid cystic carcinoma of the breast","volume":"107","author":"Fukuoka","year":"1999","journal-title":"APMIS Acta Pathol Microbiol Immunol Scand"},{"issue":"4","key":"10.1016\/j.semdp.2026.151028_bib0053","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00000478-200204000-00002","article-title":"Solid variant of mammary adenoid cystic carcinoma with basaloid features: a study of nine cases","volume":"26","author":"Shin","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.semdp.2026.151028_bib0054","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1066896915606973","article-title":"Solid variant of adenoid cystic carcinoma of the breast: a case series with proposal of a new grading system","volume":"24","author":"Foschini","year":"2016","journal-title":"Int J Surg Pathol"},{"issue":"44","key":"10.1016\/j.semdp.2026.151028_bib0055","doi-asserted-by":"crossref","first-page":"18740","DOI":"10.1073\/pnas.0909114106","article-title":"Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck","volume":"106","author":"Persson","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.semdp.2026.151028_bib0056","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/path.5006","article-title":"MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene","volume":"244","author":"Kim","year":"2018","journal-title":"J Pathol"},{"issue":"7","key":"10.1016\/j.semdp.2026.151028_bib0057","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/PAS.0000000000001913","article-title":"MYB RNA In situ hybridization is a useful diagnostic tool to distinguish breast adenoid cystic carcinoma from other triple-negative breast carcinomas","volume":"46","author":"Butcher","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.semdp.2026.151028_bib0058","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/PAS.0000000000000878","article-title":"MYB labeling by immunohistochemistry is more sensitive and specific for breast adenoid cystic carcinoma than MYB labeling by FISH","volume":"41","author":"Poling","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0059","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/path.2974","article-title":"Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers","volume":"226","author":"Wetterskog","year":"2012","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.semdp.2026.151028_bib0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/path.4573","article-title":"Genomic landscape of adenoid cystic carcinoma of the breast","volume":"237","author":"Martelotto","year":"2015","journal-title":"J Pathol"},{"key":"10.1016\/j.semdp.2026.151028_bib0061","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.943887","article-title":"Comparative proteomic and clinicopathological analysis of breast adenoid cystic carcinoma and basal-like triple-negative breast cancer","volume":"9","author":"Yao","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.semdp.2026.151028_bib0062","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.breast.2016.11.017","article-title":"Adjuvant radiation therapy and survival for adenoid cystic carcinoma of the breast","volume":"31","author":"Sun","year":"2017","journal-title":"Breast Edinb Scotl"},{"issue":"15","key":"10.1016\/j.semdp.2026.151028_bib0063","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.3390\/jcm11154477","article-title":"Adenoid cystic carcinoma of the breast may be exempt from adjuvant chemotherapy","volume":"11","author":"Li","year":"2022","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.semdp.2026.151028_bib0064","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/s41379-018-0005-y","article-title":"Adenoid cystic carcinomas of the salivary gland, lacrimal gland, and breast are morphologically and genetically similar but have distinct microRNA expression profiles","volume":"31","author":"Andreasen","year":"2018","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0065","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41389-020-0194-3","article-title":"ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma","volume":"9","author":"Andersson","year":"2020","journal-title":"Oncogenesis"},{"issue":"2","key":"10.1016\/j.semdp.2026.151028_bib0066","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1873-3468.14786","article-title":"The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma","volume":"598","author":"Cicir\u00f2","year":"2024","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0067","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00428-003-0923-y","article-title":"Mucoepidermoid carcinoma of the breast","volume":"444","author":"Di Tommaso","year":"2004","journal-title":"Virchows Arch Int J Pathol"},{"issue":"12","key":"10.1016\/j.semdp.2026.151028_bib0068","first-page":"3192","article-title":"Breast mucoepidermoid carcinoma: a case report and review of literature","volume":"13","author":"Ye","year":"2020","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"10.1016\/j.semdp.2026.151028_bib0069","doi-asserted-by":"crossref","first-page":"439","DOI":"10.21037\/gs-23-372","article-title":"Mucoepidermoid carcinoma-a rare salivary gland-type tumor of the breast: are we dealing with primary or secondary?-a case report and literature review","volume":"13","author":"Zhang","year":"2024","journal-title":"Gland Surg"},{"issue":"3","key":"10.1016\/j.semdp.2026.151028_bib0070","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5114\/pjp.2013.38141","article-title":"Primary mucoepidermoid carcinoma of the breast: a case report with immunohistochemical analysis and comparison with salivary gland mucoepidermoid carcinomas","volume":"64","author":"Palermo","year":"2013","journal-title":"Pol J Pathol Off J Pol Soc Pathol"},{"issue":"3","key":"10.1016\/j.semdp.2026.151028_bib0071","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/his.13779","article-title":"CRTC1-MAML2 fusion in mucoepidermoid carcinoma of the breast","volume":"74","author":"Bean","year":"2019","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0072","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1158\/1078-0432.CCR-16-0720","article-title":"Whole-exome sequencing of salivary gland mucoepidermoid carcinoma","volume":"23","author":"Kang","year":"2017","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"7","key":"10.1016\/j.semdp.2026.151028_bib0073","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/1066896920916779","article-title":"Mucoepidermoid carcinoma of the breast With MAML2 rearrangement: a case report and literature review","volume":"28","author":"Yan","year":"2020","journal-title":"Int J Surg Pathol"},{"issue":"10","key":"10.1016\/j.semdp.2026.151028_bib0074","article-title":"Genetic and immunohistochemical profiling of mammary hidradenoma and comparison to mucoepidermoid carcinoma","volume":"36","author":"Black","year":"2023","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"6","key":"10.1016\/j.semdp.2026.151028_bib0075","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.humpath.2008.11.004","article-title":"Mucoepidermoid carcinoma of the breast shares cytogenetic abnormality with mucoepidermoid carcinoma of the salivary gland: a case report with molecular analysis and review of the literature","volume":"40","author":"Camelo-Piragua","year":"2009","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1016\/j.semdp.2026.151028_bib0076","doi-asserted-by":"crossref","first-page":"10725","DOI":"10.1002\/cam4.5754","article-title":"The molecular landscape of breast mucoepidermoid carcinoma","volume":"12","author":"Venetis","year":"2023","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0077","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13000-024-01439-8","article-title":"Genomics and tumor microenvironment of breast mucoepidermoid carcinoma based on whole-exome and RNA sequencing","volume":"19","author":"Ge","year":"2024","journal-title":"Diagn Pathol"},{"issue":"5","key":"10.1016\/j.semdp.2026.151028_bib0078","first-page":"423","article-title":"Low and high grade mucoepidermoid carcinomas of the breast","volume":"23","author":"Tjalma","year":"2002","journal-title":"Eur J Gynaecol Oncol"},{"issue":"7","key":"10.1016\/j.semdp.2026.151028_bib0079","article-title":"RNA In Situ hybridization detection of CRTC1\/3::MAML2 fusions and LINC00473 in mucoepidermoid carcinomas and hidradenomas of breast, salivary glands, and skin","volume":"38","author":"Rutland","year":"2025","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"5","key":"10.1016\/j.semdp.2026.151028_bib0080","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00000478-198705000-00003","article-title":"Low-grade adenosquamous carcinoma. A variant of metaplastic mammary carcinoma","volume":"11","author":"Rosen","year":"1987","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.semdp.2026.151028_bib0081","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00000478-199303000-00005","article-title":"Low-grade adenosquamous carcinoma of the breast. A clinocopathologic study of 32 cases with ultrastructural analysis","volume":"17","author":"Van Hoeven","year":"1993","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.semdp.2026.151028_bib0082","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2559.2000.00849.x","article-title":"Metaplastic carcinoma of the breast arising within complex sclerosing lesion: a report of five cases","volume":"36","author":"Denley","year":"2000","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0083","first-page":"85","article-title":"Bilateral, multicentric low-grade adenosquamous carcinomas of the breast, each arising within a separate radial scar\/complex sclerosing lesion","volume":"46","author":"Wilsher","year":"2014","journal-title":"Pathology (Phila)"},{"issue":"3","key":"10.1016\/j.semdp.2026.151028_bib0084","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00203390","article-title":"Adenomyoepithelioma of the breast associated with low-grade adenosquamous and sarcomatoid carcinomas","volume":"427","author":"Foschini","year":"1995","journal-title":"Virchows Arch Int J Pathol"},{"key":"10.1016\/j.semdp.2026.151028_bib0085","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijsu.2015.05.010","article-title":"Low-grade adenosquamous carcinoma of the breast: a diagnostic and clinical challenge","volume":"19","author":"Tan","year":"2015","journal-title":"Int J Surg Lond Engl"},{"issue":"2","key":"10.1016\/j.semdp.2026.151028_bib0086","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/his.13514","article-title":"High rate of PIK3CA mutations but no TP53 mutations in low-grade adenosquamous carcinoma of the breast","volume":"73","author":"Bataillon","year":"2018","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.semdp.2026.151028_bib0087","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.carj.2012.09.002","article-title":"Low-grade adenosquamous carcinoma of the breast: imaging and histopathologic characteristics of this rare disease","volume":"64","author":"Scali","year":"2013","journal-title":"Can Assoc Radiol J J Assoc Can Radiol"},{"issue":"2","key":"10.1016\/j.semdp.2026.151028_bib0088","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/his.14917","article-title":"Low-grade adenosquamous carcinoma of the breast: a clinical, morphological and immunohistochemical analysis of 25 patients","volume":"83","author":"Lewis","year":"2023","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.semdp.2026.151028_bib0089","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/PAS.0b013e31824e0f90","article-title":"Immunohistochemical staining characteristics of low-grade adenosquamous carcinoma of the breast","volume":"36","author":"Kawaguchi","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.semdp.2026.151028_bib0090","first-page":"951","article-title":"Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breast","volume":"23","author":"Geyer","year":"2010","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"10.1016\/j.semdp.2026.151028_bib0091","article-title":"Comparison of PIK3CA mutation prevalence in breast cancer across predicted ancestry populations","volume":"6","author":"Chen","year":"2022","journal-title":"JCO Precis Oncol"},{"issue":"4","key":"10.1016\/j.semdp.2026.151028_bib0092","article-title":"Low-grade adenosquamous carcinoma of the breast: a review with focus on imaging and management","volume":"10","author":"Romanucci","year":"2021","journal-title":"Acta Radiol Open"},{"issue":"10","key":"10.1016\/j.semdp.2026.151028_bib0093","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2170::AID-CNCR11>3.0.CO;2-X","article-title":"Metaplastic breast tumors with a dominant fibromatosis-like phenotype have a high risk of local recurrence","volume":"85","author":"Gobbi","year":"1999","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0094","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00428-021-03163-w","article-title":"Breast carcinomas of low malignant potential","volume":"480","author":"Schnitt","year":"2022","journal-title":"Virchows Arch Int J Pathol"},{"issue":"8","key":"10.1016\/j.semdp.2026.151028_bib0095","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/00000478-200108000-00004","article-title":"Low-grade (fibromatosis-like) spindle cell carcinoma of the breast","volume":"25","author":"Sneige","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.semdp.2026.151028_bib0096","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/10668969231171936","article-title":"Immunohistochemical characterization of a large cohort of triple negative breast cancer","volume":"32","author":"Han","year":"2024","journal-title":"Int J Surg Pathol"},{"issue":"3","key":"10.1016\/j.semdp.2026.151028_bib0097","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1159\/000526535","article-title":"Fibromatosis-like metaplastic carcinoma: a triple-negative breast cancer with clinically indolent behavior","volume":"15","author":"Pham","year":"2022","journal-title":"Case Rep Oncol"},{"issue":"11","key":"10.1016\/j.semdp.2026.151028_bib0098","first-page":"1438","article-title":"\u03b2-catenin\/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast","volume":"23","author":"Lacroix-Triki","year":"2010","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"2","key":"10.1016\/j.semdp.2026.151028_bib0099","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00428-014-1603-9","article-title":"Fibromatosis-like metaplastic carcinoma of the breast has a claudin-low immunohistochemical phenotype","volume":"465","author":"Rito","year":"2014","journal-title":"Virchows Arch Int J Pathol"},{"issue":"5","key":"10.1016\/j.semdp.2026.151028_bib0100","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/jclinpath-2014-202824","article-title":"Low-grade fibromatosis-like spindle cell carcinomas of the breast are molecularly exiguous","volume":"68","author":"Takano","year":"2015","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0101","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13000-020-00943-x","article-title":"Fibromatosis-like metaplastic carcinoma: a case report and review of the literature","volume":"15","author":"Victoor","year":"2020","journal-title":"Diagn Pathol"},{"issue":"7","key":"10.1016\/j.semdp.2026.151028_bib0102","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/jclinpath-2020-207071","article-title":"High frequency of PIK3CA and TERT promoter mutations in fibromatosis-like spindle cell carcinomas","volume":"75","author":"Zhong","year":"2022","journal-title":"J Clin Pathol"},{"issue":"12","key":"10.1016\/j.semdp.2026.151028_bib0103","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.5858\/arpa.2022-0159-OA","article-title":"TERT Promoter mutation c.-124C>T commonly occurs in low-grade fibromatosis-like metaplastic breast carcinoma","volume":"147","author":"Webersinke","year":"2023","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.semdp.2026.151028_bib0104","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2025.102885","article-title":"Therapeutic strategies and landscape of metaplastic breast cancer","volume":"133","author":"Dai","year":"2025","journal-title":"Cancer Treat Rev"},{"issue":"8","key":"10.1016\/j.semdp.2026.151028_bib0105","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/00000478-200308000-00008","article-title":"Breast tumor resembling the tall cell variant of papillary thyroid carcinoma: report of 5 cases","volume":"27","author":"Eusebi","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.semdp.2026.151028_bib0106","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/PAS.0000000000000853","article-title":"Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms: a unique invasive tumor with indolent behavior","volume":"41","author":"Foschini","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.semdp.2026.151028_bib0107","first-page":"1367","article-title":"Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional cases","volume":"31","author":"Alsadoun","year":"2018","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"2","key":"10.1016\/j.semdp.2026.151028_bib0108","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/his.13522","article-title":"Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations affecting IDH2 and PIK3CA: a validation cohort","volume":"73","author":"Lozada","year":"2018","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.semdp.2026.151028_bib0109","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/1066896918800779","article-title":"Breast tumor resembling the tall cell variant of papillary thyroid carcinoma: molecular characterization by next-generation sequencing and histopathological comparison with tall cell papillary carcinoma of thyroid","volume":"27","author":"Zhong","year":"2019","journal-title":"Int J Surg Pathol"},{"issue":"4","key":"10.1016\/j.semdp.2026.151028_bib0110","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/ajcp\/aqx016","article-title":"Breast tumor resembling tall cell variant of papillary thyroid carcinoma: a solid papillary neoplasm with characteristic immunohistochemical profile and few recurrent mutations","volume":"147","author":"Bhargava","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"24","key":"10.1016\/j.semdp.2026.151028_bib0111","doi-asserted-by":"crossref","first-page":"7118","DOI":"10.1158\/0008-5472.CAN-16-0298","article-title":"IDH2 mutations define a unique subtype of breast cancer with altered nuclear polarity","volume":"76","author":"Chiang","year":"2016","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.semdp.2026.151028_bib0112","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1066896914536222","article-title":"An additional case of breast tumor resembling the tall cell variant of papillary thyroid carcinoma","volume":"23","author":"Colella","year":"2015","journal-title":"Int J Surg Pathol"},{"issue":"4","key":"10.1016\/j.semdp.2026.151028_bib0113","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/ajcp\/aqx016","article-title":"Breast tumor resembling tall cell variant of papillary thyroid carcinoma: a solid papillary neoplasm with characteristic immunohistochemical profile and few recurrent mutations","volume":"147","author":"Bhargava","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.semdp.2026.151028_bib0114","first-page":"183","article-title":"Tall Cell Carcinoma with Reverse Polarity of Breast: report of a Case with Unique Morphologic and Molecular Features","volume":"37","author":"Jassim","year":"2021","journal-title":"Turk Patoloji Derg"},{"issue":"6","key":"10.1016\/j.semdp.2026.151028_bib0115","first-page":"1056","article-title":"Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity","volume":"33","author":"Pareja","year":"2020","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"6","key":"10.1016\/j.semdp.2026.151028_bib0116","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1007\/s11033-020-05553-w","article-title":"Tall cell carcinoma of the breast with reversed polarity (TCCRP) with mutations in the IDH2 and PIK3CA genes: a case report","volume":"47","author":"Haefliger","year":"2020","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.semdp.2026.151028_bib0117","article-title":"Tall Cell Carcinoma with Reversed Polarity of the breast: clinicopathological insights, molecular profile, and future therapeutic directions","volume":"82","author":"Lu","year":"2025","journal-title":"Breast Edinb Scotl"},{"issue":"11","key":"10.1016\/j.semdp.2026.151028_bib0118","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.21037\/gs-21-591","article-title":"Tall cell carcinoma with reversed polarity: case report with gene sequencing and literature review","volume":"10","author":"Wei","year":"2021","journal-title":"Gland Surg"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0119","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41523-025-00719-w","article-title":"Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes","volume":"11","author":"Pareja","year":"2025","journal-title":"NPJ Breast Cancer"},{"issue":"10","key":"10.1016\/j.semdp.2026.151028_bib0120","first-page":"654","article-title":"The diagnostic utility of IDH2 R172 immunohistochemistry in tall cell carcinoma with reversed polarity of the breast","volume":"30","author":"Sasaki","year":"2022","journal-title":"Appl Immunohistochem Mol Morphol AIMM"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0121","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ajhg.2017.05.013","article-title":"Ultra-sensitive sequencing identifies high prevalence of clonal hematopoiesis-associated mutations throughout adult life","volume":"101","author":"Acuna-Hidalgo","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.semdp.2026.151028_bib0122","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJMoa1913948","article-title":"Breast cancer risk genes - association analysis in more than 113,000 Women","volume":"384","author":"Breast Cancer Association Consortium","year":"2021","journal-title":"N Engl J Med."},{"issue":"43","key":"10.1016\/j.semdp.2026.151028_bib0123","doi-asserted-by":"crossref","first-page":"69903","DOI":"10.18632\/oncotarget.12065","article-title":"Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers","volume":"7","author":"Linklater","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.semdp.2026.151028_bib0124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102176","article-title":"The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFR\u03b1, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer","volume":"9","author":"Jansson","year":"2014","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.semdp.2026.151028_bib0125","article-title":"Frank invasion in tall cell carcinoma with reversed polarity of the breast: report of two cases","volume":"38","author":"Han","year":"2025","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"10.1016\/j.semdp.2026.151028_bib0126","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1455893","article-title":"Case report: triple-negative breast cancer with low tumour-infiltrating lymphocytes infiltration and good prognosis: a case of tall cell carcinoma with reversed polarity and review of the literature","volume":"14","author":"Jiao","year":"2024","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0127","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/106689690601400116","article-title":"Breast tumor resembling the tall cell variant of papillary thyroid carcinoma: a case report","volume":"14","author":"Cameselle-Teijeiro","year":"2006","journal-title":"Int J Surg Pathol"},{"issue":"10","key":"10.1016\/j.semdp.2026.151028_bib0128","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1245\/s10434-021-10518-9","article-title":"Apocrine Breast Cancer: unique Features of a Predominantly Triple-Negative Breast Cancer","volume":"28","author":"Saridakis","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.semdp.2026.151028_bib0129","article-title":"Triple-negative apocrine carcinomas: toward a unified group with shared molecular features and clinical behavior","volume":"36","author":"Schwartz","year":"2023","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"5","key":"10.1016\/j.semdp.2026.151028_bib0130","first-page":"644","article-title":"EGFR and HER-2\/neu expression in invasive apocrine carcinoma of the breast","volume":"23","author":"Vranic","year":"2010","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0131","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/jclinpath-2011-200318","article-title":"Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity","volume":"65","author":"Lin","year":"2012","journal-title":"J Clin Pathol"},{"issue":"12","key":"10.1016\/j.semdp.2026.151028_bib0132","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1136\/jclinpath-2012-200885","article-title":"Reappraisal of immunohistochemical profiling of special histological types of breast carcinomas: a study of 121 cases of eight different subtypes","volume":"65","author":"Alvarenga","year":"2012","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0133","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13058-018-0933-y","article-title":"HER2 is not a cancer subtype but rather a pan-cancer event and is highly enriched in AR-driven breast tumors","volume":"20","author":"Daemen","year":"2018","journal-title":"Breast Cancer Res BCR"},{"issue":"8","key":"10.1016\/j.semdp.2026.151028_bib0134","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/PAS.0000000000000671","article-title":"Pure apocrine carcinomas represent a clinicopathologically distinct androgen receptor-positive subset of triple-negative breast cancers","volume":"40","author":"Mills","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.semdp.2026.151028_bib0135","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00428-021-03028-2","article-title":"Chromosome X aneusomy and androgen receptor gene copy number aberrations in apocrine carcinoma of the breast","volume":"479","author":"Cremonini","year":"2021","journal-title":"Virchows Arch Int J Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0136","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1038\/s41598-025-87403-y","article-title":"Relationship between androgen receptor and androgen receptor-related protein expression in breast cancers focusing on morphologically identified carcinoma with apocrine differentiation","volume":"15","author":"Nishida","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.semdp.2026.151028_bib0137","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.humpath.2016.04.013","article-title":"Expression patterns of GATA3 and the androgen receptor are strongly correlated in patients with triple-negative breast cancer","volume":"55","author":"Kim","year":"2016","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0138","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0002-9440(10)63959-4","article-title":"Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast","volume":"158","author":"Jones","year":"2001","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.semdp.2026.151028_bib0139","first-page":"476","article-title":"Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology","volume":"29","author":"Weisman","year":"2016","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"12","key":"10.1016\/j.semdp.2026.151028_bib0140","first-page":"2473","article-title":"Invasive apocrine carcinoma of the breast: clinicopathologic features and comprehensive genomic profiling of 18 pure triple-negative apocrine carcinomas","volume":"33","author":"Sun","year":"2020","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"4","key":"10.1016\/j.semdp.2026.151028_bib0141","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2626","article-title":"Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations","volume":"12","author":"Banneau","year":"2010","journal-title":"Breast Cancer Res BCR"},{"issue":"15","key":"10.1016\/j.semdp.2026.151028_bib0142","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1158\/0008-5472.CAN-07-6854","article-title":"An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer","volume":"68","author":"Stemke-Hale","year":"2008","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.semdp.2026.151028_bib0143","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/bjc.2016.403","article-title":"Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors","volume":"116","author":"Uusitalo","year":"2017","journal-title":"Br J Cancer"},{"issue":"14","key":"10.1016\/j.semdp.2026.151028_bib0144","doi-asserted-by":"crossref","first-page":"17301","DOI":"10.18632\/oncotarget.8191","article-title":"Oncogenic AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis","volume":"7","author":"Mancini","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.semdp.2026.151028_bib0145","first-page":"924","article-title":"Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses\u2019 Health Study","volume":"24","author":"Collins","year":"2011","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"9","key":"10.1016\/j.semdp.2026.151028_bib0146","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/PAS.0000000000002073","article-title":"Triple-negative breast carcinoma with apocrine and histiocytoid features: a clinicopathologic and molecular study of 18 cases","volume":"47","author":"Wang","year":"2023","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2026.151028_bib0147","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1038\/s41598-021-84350-2","article-title":"Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer","volume":"11","author":"Koleckova","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.semdp.2026.151028_bib0148","doi-asserted-by":"crossref","first-page":"e773","DOI":"10.1016\/j.clbc.2018.02.012","article-title":"Triple negative apocrine carcinomas as a distinct subtype of triple negative breast cancer: a case-control study","volume":"18","author":"Meattini","year":"2018","journal-title":"Clin Breast Cancer"},{"issue":"18","key":"10.1016\/j.semdp.2026.151028_bib0149","doi-asserted-by":"crossref","first-page":"7523","DOI":"10.1002\/cam4.2634","article-title":"Prognosis in triple-negative apocrine carcinomas of the breast: a population-based study","volume":"8","author":"Wu","year":"2019","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.semdp.2026.151028_bib0150","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/jso.26129","article-title":"Triple-negative apocrine carcinoma: a rare pathologic subtype with a better prognosis than other triple-negative breast cancers","volume":"122","author":"Arciero","year":"2020","journal-title":"J Surg Oncol"},{"issue":"15","key":"10.1016\/j.semdp.2026.151028_bib0151","doi-asserted-by":"crossref","first-page":"24579","DOI":"10.18632\/oncotarget.15597","article-title":"Dose invasive apocrine adenocarcinoma has worse prognosis than invasive ductal carcinoma of breast: evidence from SEER database","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.semdp.2026.151028_bib0152","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clbc.2012.11.004","article-title":"Immunohistochemically defined subtypes and outcome of apocrine breast cancer","volume":"13","author":"Dellapasqua","year":"2013","journal-title":"Clin Breast Cancer"},{"issue":"4","key":"10.1016\/j.semdp.2026.151028_bib0153","doi-asserted-by":"crossref","first-page":"e576","DOI":"10.1016\/j.clbc.2021.12.009","article-title":"An update on the molecular and clinical characteristics of apocrine carcinoma of the breast","volume":"22","author":"Vranic","year":"2022","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"10.1016\/j.semdp.2026.151028_bib0154","first-page":"396","article-title":"Androgen receptor splice variant-7 in breast cancer: clinical and pathologic correlations","volume":"35","author":"Ferguson","year":"2022","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257026000481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257026000481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:17:47Z","timestamp":1784643467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257026000481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":154,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0740257026000481"],"URL":"https:\/\/doi.org\/10.1016\/j.semdp.2026.151028","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When three negatives equal a positive: Molecular updates of triple-negative breast carcinomas with favorable prognoses","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semdp.2026.151028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151028"}}